Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption.
Sizing and Forecast
The porcine vaccine market size has grown strongly in recent years. It will grow from $1.74 billion in 2023 to $1.91 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to disease outbreaks and control measures, global increase in pork consumption, intensification of pig farming, government initiatives for disease control, awareness and education programs.
The porcine vaccine market size is expected to see strong growth in the next few years. It will grow to $2.73 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to global expansion of pig farming, rising disease challenges, stringent regulations and compliance, technological advancements in vaccine development, global trade and disease risk mitigation. Major trends in the forecast period include customization of vaccines for regional challenges, integration of biotechnology in vaccine development, rising concerns about zoonotic diseases, application of genomic approaches in vaccine design, growing investments in research and development.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Segmentation & Regional Insights
The porcine vaccines market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm
North America is the largest region in the porcine vaccine market in 2023. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp
Major Driver Impacting Market Growth
The increasing infection of swine disease will propel the growth of the porcine vaccine market going forward. Swine influenza (swine flu) is a respiratory illness that affects pigs commonly caused by the type A influenza virus, which frequently causes influenza outbreaks in pigs. Porcine vaccines are instilled into pigs, where the pigs’ immune systems react to the vaccine and recall the pathogenic agent by inducing an immunogenic reaction. These vaccines prepare the swine’s immune system to fight against pathogens and prevent the sickness by exerting an anamnestic reaction when encountering the same pathogen. For instance, in December 2021, according to the report published by Swine Health Information Centre, a US-based agency that protects and enhances the health of swine, European countries registered 1,844 outbreaks of African Swine Fever (ASF) in domestic pigs in the year 2021. Therefore, the rising infection of swine disease is driving the porcine vaccine market.
Key Industry Players
Major companies operating in the porcine vaccine market report are Bayer AG, Sanofi Pasteur Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, ProBioGen AG, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Biozoo S.A., Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH
The porcine vaccine market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
